Case report · 27 Dec 2022
EditorialPublished 2015
Recent Progresses of Oncolytic Immunotherapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Oncolytic immunotherapy, also known as anti-tumor virotherapy, is a therapeutic approach using oncolytic viruses that preferentially or exclusively infect and kill tumor cells. In this short review, we discuss recent advances of this therapeutic strategy.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 17 Jul 2017
A novel oncolytic HSV-1 vector for cancer immunotherapy
Article · 3 Mar 2025
Recent Advances in Oral Immunotherapy for IgE-Mediated Food Allergies: A Critical Analysis of Treatment Outcomes
Commentary · 4 Sep 2024
Melanoma Immunotherapy: Its Recent Advances in Patients and Revolution
Review article · 30 Jul 2024
Role of Cytokines in Cancer Immunotherapy: Recent Advances and Clinical Applications
More from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Understanding the Immune Response to Checkpoint Inhibitors in Immunotherapy
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Jean-François Fonteneau”

